Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To §§ 130a Para. 8/130c Para. 1 Sgb V For Medicinal Products Containing The Active Ingredient Tadalafil (g04be08), Only Medicinal Products With The Indication Benign Prostate Syndrome Within The Fra 2026-12-31
Germany Tender Are Invited For  Medicinal Products Containing The Active Ingredient Iron(iii) Oxide Sucrose Complex (b03ac02) Within The Framework Of A So-called Open House Model. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. - Drug 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ritonavir (j05ae03) Within The Framework Of A So-called Open House Model. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ritonavir (j05ae03) Within The Framework Of A So-called Open House Model. 2026-12-31
Germany Medicines Containing The Active Ingredient Combination Brinzolamide And Brimonidine (atc 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Drug Discount Agreements From 01.03.2025 For Various Active Ingredients Within The Framework Of An Open House Procedure 2027-01-04
United Kingdom Provision Of Care Services In Supported Housing 2027-01-05
Ireland Dynamic Purchasing System For Non Invasive Cardiology Equipment 2027-01-05
Whats app